Dornan David 4
4 · Elevation Oncology, Inc. · Filed Feb 17, 2023
Insider Transaction Report
Form 4
Dornan David
CHIEF SCIENTIFIC OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2023-02-15+130,000→ 130,000 totalExercise: $0.98Exp: 2033-02-14→ Common Stock (130,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the total shares on February 15, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.